Authority: Supreme Court of India

Order Date: 18-09-2026

Case Overview

  • Petitioner: CIPLA LIMITED
  • Respondents: NATIONAL PHARMACEUTICAL PRICING AUTHORITY & ORS.
  • Proceeding: Petition for Special Leave to Appeal (C) No. 23021/2026, arising from the impugned final judgment and order dated 24‑04‑2026 in WP No. 2069/2022 passed by the High Court of Judicature at Bombay.
  • Bench: Hon'ble Mr. Justice Pamidighantam, Sri Narasimha, and Hon'ble Mr. Justice Alok Aradhe.
  • Counsel for Petitioner: Mr. S. Niranjan Reddy, Sr. Adv.; Mr. Aman Raj Gandhi, AOR; Ms. Bindi Girish Dave, Adv.; Mr. Aayesh Gandhi, Adv.; Mr. Parthasarathy Bose, Adv.; Mr. Dhairyah C. Shroff, Adv.; Ms. Palak Arora, Adv.
  • Counsel for Respondents: Mr. Anil Kumar Kaushik, ASG; Mr. Rajan Kumar Chourasia, Adv.; Mr. Pranjal Singh, Adv.; Mr. Sudarshan Lamba, AOR; Mr. Rajeshwari Shankar, Adv.; Ms. Anju Kaushik, Adv.; Mr. Bharat Bagla, Adv.; Mr. Siddharth Dharmadhikari, Adv.; Mr. Aaditya Aniruddha Pande, AOR; Mr. Shrirang B. Varma, Adv.

Court Directions

1. Respondents are granted a period of two weeks from the date of this order to file a counter‑affidavit.

2. The petitioner may file a rejoinder within two weeks after the counter‑affidavit is filed.

3. The matter is listed for further hearing on 06‑11‑2026.

Final Outcome

The Supreme Court issued procedural directions granting the respondents a two‑week window to submit a counter‑affidavit, permitting a subsequent two‑week rejoinder from the petitioner, and scheduled the next hearing for 6 November 2026.

Topics: Pharmaceutical Pricing, Court Procedure